UBS Group’s Qiagen QGEN Stock Holding History

UBS Group’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47,153	Closed	-$2.58M	–	10607
2021 Q3	$2.58M	Buy	+47,153	New	+$2.63M	﹤0.01%	3352
2020 Q2	–	Sell	-47,153	Closed	-$2.08M	–	8273
2020 Q1	$2.08M	Buy	+47,153	New	+$1.84M	﹤0.01%	2723
2019 Q1	–	Sell	-37,722	Closed	-$1.38M	–	8069
2018 Q4	$1.38M	Sell	37,722 -56,584	-60%	-$2.1M	﹤0.01%	3394
2018 Q3	$3.79M	Hold	94,306	–	–	﹤0.01%	2610
2018 Q2	$3.62M	Hold	94,306	–	–	﹤0.01%	2626
2018 Q1	$3.23M	Buy	+94,306	New	+$3.31M	﹤0.01%	2712
2017 Q2	–	Sell	-42,437	Closed	-$1.3M	–	7917
2017 Q1	$1.3M	Buy	+42,437	New	+$1.31M	﹤0.01%	3321

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's QGEN Position: Q1 2026 in Review

UBS Group increased its Qiagen (QGEN) stake by 24% in Q1 2026, buying an estimated $13M and bringing the position to 1,428,307 shares worth $57.2M. The position accounts for 0.01% of the portfolio, ranked #1516.

UBS Group first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $215M in Q1 2020. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

UBS Group held 1,428,307 shares of Qiagen worth $57.2M as of Q1 2026.
UBS Group bought 274,885 Qiagen shares in Q1 2026, an estimated $13M.
Qiagen made up 0.01% of UBS Group's portfolio in Q1 2026, its #1516 holding.
UBS Group first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
UBS Group's Qiagen position peaked at $215M in Q1 2020.
344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.